ECHO Connection

  • EDUCATION
    • EDUCATION BLOG
  • COLLABORATION
    • DOCTOR SIGNUP
  • HOPE
    • ECHO FAMILIES
    • APPLICATION
  • ABOUT
    • ORGANIZATION UPDATES
    • CONTACT
DONATEEuropean Donation

What is Clinical Endocannabinoid Deficiency?

by ECHO / Wednesday, 10 May 2017 / Published in Education, Overview of Cannabinoids

Researchers believe that the underlying cause of many ailments, particularly those related to the immune system and inflammation, could be a disorder referred to as clinical endocannabinoid deficiency.

Endocannabinoid deficiency is a theory for the symptoms and conditions that develop when the body’s endocannabinoid system isn’t functioning properly. We’ve previously discussed the endocannabinoid system and its role in regulating a wide array of body processes to maintain our health. The body naturally produces neuromodulatory lipids called endocannabinoids, which interact cannabinoid receptors throughout the body to elicit chemical responses that keep the body in balance.

The theory of clinical endocannabinoid deficiency suggests that in some cases the body doesn’t produce enough endocannabinoids or enough receptors for the endocannabinoid system to function properly. As a result, the many functions aren’t regulated properly and the body becomes unbalanced, allowing diseases to arise.

Renowned cannabinoid researcher Dr. Ethan Russo first proposed the theory of clinical endocannabinoid deficiency in 2004. In a study, published in Neuro Endocrinology Letters, Russo suggested that deficient cannabinoid levels might explain why some conditions develop.

Russo had examined the available literature and found evidence that people diagnosed with certain conditions had lower levels of endocannabinoids. He suggested that a person being deficient in endocannabinoids and/or cannabinoid receptors could explain why supplementing with cannabinoids found in plants like hemp were proving effective at alleviating some conditions.

“Migraine, fibromyalgia, [irritable bowel syndrome] and related conditions display common clinical, biochemical and pathophysiological patterns that suggests an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines,” Russo concluded in his research review.

Cannabinoids found in plants like hemp, including cannabidiol (CBD), are analogous to the endocannabinoids naturally produced by the body. Research shows that they interact with the cannabinoid receptors of the endocannabinoid system to elicit chemical responses that help bring about homeostasis.

A deficiency in endocannabinoids has been linked to several other disorders besides migraine, fibromyalgia and irritable bowel syndrome. The endocannabinoid system is responsible for regulating the release of neurotransmitter, so diseases that are attributed to their dysfunction, such as Alzheimer’s disease and Parkinson’s disease, may be related to clinical endocannabinoid deficiency.

While more research needs to be done before endocannabinoid deficiency can be proven, the theory could open the door for methods to prevent and manage certain conditions. Russo believes cannabinoids from cannabis plants like hemp are essential nutrients that can minimize certain diseases by assisting the endocannabinoid system and ensuring that it functions properly.


Interested in learning more about cannabinoids and the therapeutic properties they offer through interaction with the endocannabinoid system? We recommend you visit our Education page and read through these articles:

  • The Endocannabinoid System
  • A Look at the Endocannabinoid System’s CB1 and CB2 Receptors
  • Summary of Conditions Affected by Cannabinoids and the Endocannabinoid System
  • 5 Most Frequently Asked Questions about CBD

Be sure to follow us on Facebook, Twitter, Instagram, and Pinterest for the latest updates.

Tagged under: Cannabinoids, education, Endocannabinoid System, Endocannabinoids

What you can read next

What are Cannabinoids?
CBD Beverages: Do They Work?
Here’s Why It’s Best to Take CBD Oil Everyday

Recent Posts

  • ECHO Announces Changes to Leadership

    We are making a few changes at ECHO Connection ...
  • Five States That Will Definitely Have Cannabis Legalization on the Ballot in November

    In any other year, cannabis legalization on the...
  • The Top Six CBD Podcasts to Listen to This Fall

    It’s no secret that the world is on a can...
  • Study Shows That Many CBD Beverages Contain Less or More Cannabidiol Than Advertised

    With CBD beverages increasing in popularity, it...
  • Beyond Ancestry—Cannabis DNA Tests Could Help You Find Your Ideal Strain

    By now, we’re all familiar with DNA test kits. ...

Receive the latest ECHO news by joining our newsletter.

  • Home
  • Education
  • Collaboration
  • Hope
  • ECHO Families
  • About
  • Blog
  • Contact

Privacy Policy   |   Terms of Use

Image credits: CMW Media

Notice: ECHO Connection is a 501(c)(3) non-profit organization, U.S. Federal Tax ID 81-4542024.  ECHO is also recognized as a charitable organization, Algemeen nut Beogende Instelling (ANBI) in the Netherlands, RSIN 8256 57 520.

2017 ECHO Connection™ - All Rights Reserved

TOP
ECHO Connection Website

The information contained in this website is for general information and educational purposes only. It does not constitute medical advice. Therefore, any reliance you place on such information is strictly at your own risk. Please check with your medical doctor before starting or changing your CBD routine.

By entering this site you agree to our TERMS OF SERVICE and PRIVACY POLICY.